Choosing the right metrics for a successful healthcare launch
Measuring the success of a pharmaceutical or healthcare product launch is a crucial yet often debated topic. With so many potential metrics to track, it is easy to focus on data points that are readily available but offer little insight into long-term success. The key to an effective launch measurement strategy is identifying metrics that go beyond surface-level indicators and provide a true picture of engagement, adoption and sustained impact.
Through our work with launch teams across different therapy areas, we have seen the distinction between metrics that drive actionable insights and those that can mislead or create internal friction. To help teams focus on what truly matters, we have outlined the most effective metrics for launch performance, as well as those that may seem useful but often fail to provide meaningful guidance.
Metrics that matter: Tracking real engagement and action
A successful launch is not just about sales figures, but rather ensuring the right patients receive the right treatment at the right time. The best launch metrics reflect both commercial performance and the level of engagement among key stakeholders.
Tracking sales performance is, of course, essential, but it must be done in the right context. Looking at patient packs dispensed by territory and month after access is secured provides a more accurate view of product uptake. Equally important is understanding how proactively healthcare professionals seek information about the new product. A high number of unsolicited requests from clinicians signals strong market interest and confidence in the treatment.
Pre-launch awareness plays a critical role in shaping uptake. Measuring target healthcare professionals’ awareness of the unmet need, as well as their familiarity with pivotal trial results, offers an early indication of whether the launch strategy is resonating. The level of engagement from key opinion leaders is another valuable indicator. Tracking how often they share congress highlights with their peers, both online and offline, provides insight into how well the scientific narrative is being communicated.
Once a product is available, ongoing engagement is a key measure of success. The number of downloads of healthcare professional resources from product websites can indicate interest and the perceived value of supporting materials. More importantly, tracking prescribing intent at three, six and twelve months post-launch gives a strong sense of whether initial awareness is translating into clinical adoption. Understanding target doctors’ perceptions of the patient experience further refines this view, ensuring that the product delivers on its promises in real-world settings.
Measuring channel effectiveness is equally critical. Understanding which channels are most effective in engaging target prescribers allows teams to refine their communication strategy. Internally, assessing the skills and confidence levels of launch team members both before and after launch ensures that everyone is equipped to drive success.
The pitfalls: Metrics that create noise instead of clarity
While it may be tempting to track every available data point, some commonly used metrics can be misleading or fail to provide actionable insights. One of the most frequent missteps is measuring sales before national access is secured. Without full market availability, sales figures do not reflect true demand and can lead to inaccurate forecasting.
Sales force call activity is another widely used but often unhelpful metric. Measuring the number of calls made does not necessarily correlate with engagement or prescribing behaviour. Similarly, completing a launch readiness checklist is not an indicator of success. While essential for internal planning, a completed checklist does not guarantee that the strategy will translate into strong market performance.
Comparing monthly sales uptake across different countries can also be problematic. Each market has unique regulatory environments, access pathways and prescribing behaviours, making direct comparisons unreliable. Counting the number of attendees at launch meetings and congresses can be equally misleading. A packed room does not necessarily indicate meaningful engagement or intent to prescribe.
Website traffic, often used as a digital metric, must be assessed carefully. Hits on a healthcare professional portal do not indicate whether the right people are accessing the right information or taking action based on what they see. Similarly, tracking awareness levels at fixed time points, such as three, six and twelve months post-launch, does not provide the full picture unless paired with intent to prescribe and real-world prescribing data.
Recalling key messages is another frequently used but limited metric. While message recall is important, it does not confirm whether those messages are influencing clinical decision making. Additionally, comparing the size of the launch budget against competitors in the first year does not account for differences in strategy, market conditions or access challenges. Finally, broad market research efforts without clear objectives can generate data but fail to provide meaningful direction for strategic adjustments.
Setting your launch up for success
Selecting the right metrics for a launch requires careful thought and alignment across teams. The most effective launch measurement strategies prioritise metrics that reflect real engagement, prescribing intent and patient impact. By focusing on meaningful indicators, teams can make informed decisions, refine their approach and maximise long-term success.
If you need support in defining the right launch metrics for your specific market, we can help. Get in touch to explore how our tailored benchmarking and measurement strategies can optimise your launch performance and ensure a successful market entry.
Discover our concise list of the best and worst metrics below
The Good List:
- Sales, patient packs by territory, by month, post-access
- Number of proactive requests from HCPs* for new product information
- Target HCPs’* pre-launch information awareness of unmet need
- Target HCPs’* pre-launch awareness of pivotal trial results
- KOL** sharing of congress symposium highlights to peers online and offline
- Number of downloads of HCP* website resources
- Target doctors’ intent to prescribe, trial and repeat prescription at 3, 6, 12 months
- Target doctors’ perception of positive patient experience
- Channel effectiveness KPIs to engage with target doctors
- Skills and belief levels of all key internal launch team members pre- and post-launch
The Naughty List:
- Sales before national access is secured
- Sales force call activity
- Launch readiness activity tick box list complete
- Sales uptake per month vs other countries
- Numbers of attendees at launch meetings and congresses
- Hits on HCP* website
- Target doctors’ awareness at 3, 6, 12 months
- Target doctors’ recall of 3 key messages
- Size of launch budget vs competition in year 1
- Market research (measuring what exactly?!)
Contact us
